Company Filing History:
3 out of 611 
1 out of 2 Years Active: 2015-2019
Title: Tieming Cheng: Innovator in Pharmaceutical Chemistry
Introduction
Tieming Cheng is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 3 patents, Cheng has focused on developing compounds that have therapeutic applications.
Latest Patents
Cheng's latest patents include a urea peptoid boric acid compound and its pharmaceutical composition, which provides a novel approach to treating various medical conditions. This invention outlines the preparative methods and uses of the urea peptidomimetic boronic compound, represented by a specific formula. Another notable patent involves tripeptide boronic acids or boronic esters, which serve as proteasome inhibitors. These compounds are designed to treat malignant tumors, degenerative diseases of the nervous system, muscle cachexia, and diabetes, with specific applications for leukemia, gastric cancer, hepatocarcinoma, and nasopharyngeal carcinoma.
Career Highlights
Throughout his career, Tieming Cheng has worked with esteemed institutions such as Peking University and Zhengzhou Granlen Pharmatech Ltd. His work has been instrumental in advancing pharmaceutical research and development.
Collaborations
Cheng has collaborated with notable colleagues, including Runtao Li and Zemei Ge, contributing to a rich exchange of ideas and innovations in his field.
Conclusion
Tieming Cheng's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of therapeutic agents for critical health issues.